Tag Archives: Unapproved Drug

Altuzan bevacizumab Counterfeit Product

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Altuzan (bevacizumab): Counterfeit Product – Contains no Active Ingredient   ISSUE: FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found … Continue reading

Share
Posted in Family Practice, FDA 2012, FDA Recall, FDA Warning, Healthcare Professionals, Oncology, Patients | Tagged , , , , , , , , , , , , , , , , | Comments Off

Brilliant Blue G Recall

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseBrilliant Blue G: Recall of Unapproved Drug – Ongoing Investigation of Fungal Endophthalmitis Cases AUDIENCE: Ophthalmology, Risk Manager ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients … Continue reading

Share
Posted in FDA 2012, FDA Recall, Ophthalmology, Risk Manager | Tagged , , , , , , , , , , , , | Comments Off